At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-blind, Placebo-controlled Clinical Trial Evaluating the Safety and Efficacy of Oral Recombinant Salmon Calcitonin (rsCT) in the Prevention of Postmenopausal Osteoporosis in Women at Increased Risk of Fracture
In Brief
A Phase 2 clinical trial evaluating Oral calcitonin at dinnertime, Oral placebo at dinnertime, and 2 other interventions for Osteopenia. Completed, enrolled 129 participants across 10 sites.
Detailed Summary
The primary purpose of this study was to evaluate the efficacy of oral calcitonin (rsCT)tablets in the prevention of bone loss in postmenopausal women with lower bone mineral density at increased risk of fracture. The secondary purpose of this study was to determine if there is any food effect by comparing the efficacy and safety of oral calcitonin tablets administered at dinner or at bedtime.
Study Details
Timeline
Interventions
Oral calcitonin at dinnertime.
Oral placebo at dinnertime.
Oral calcitonin at bedtime
Oral placebo at bedtime